How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Preclinical MRI Equipment Market
- By Magnet Type: Superconducting MRI, Permanent MRI, Resistive MRI
- By Field Strength: Low Field (<1 Tesla), Mid Field (1-3 Tesla), High Field (3-7 Tesla), Ultra High Field (>7 Tesla)
- By Application: Neuroscience Research, Oncology Research, Cardiovascular Research, Pharmacology and Drug Discovery, Musculoskeletal Research
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals and Medical Centers
- By Component Type: MRI Scanners, RF Coils, Gradient Systems, Software and Imaging Solutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Superconducting MRI leads By Magnet Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 8 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 8 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Preclinical MRI Equipment Market report
A complete, evidence-based study - 12 chapters and 116 sections covering market size, segmentation across 5 axes, regional analysis and 8 company profiles, forecast to 2033.
Segmentation covered
Magnet Type 3
Field Strength 4
Application 5
End User 4
Component Type 4
Companies profiled
Bruker Corporation
Agilent Technologies (formerly Varian Medical Systems)
Aspect Imaging
MR Solutions
Magritek
nanoScan (Mediso)
MR Instruments Inc.
Bruker BioSpin
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
8 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bruker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Agilent Technologies (formerly Varian Medical Systems)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Aspect Imaging
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →MR Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Magritek
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →nanoScan (Mediso)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →MR Instruments Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.191 →Bruker BioSpin
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.196 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,685M by 2033 · 3.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Superconducting MRI58.3
- Permanent MRI21.8
- Resistive MRI19.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$412.5M → $505.4M · 2.6%
Europe$287.5M → $432.2M · 5.2%
Asia Pacific$262.5M → $313.8M · 2.3%
Latin America$162.5M → $238.9M · 4.9%
Middle East and Africa$125.0M → $188.0M · 5.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.752026
3.772027
3.772028
3.782029
3.802030
3.812031
3.832032
3.842033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bruker Corporation21.4
- Agilent Technologies (formerly Varian Medical Systems)19.6
- Aspect Imaging8.9
- MR Solutions9.2
- Magritek7.9
- nanoScan (Mediso)4.9
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Magnet Type13.7%
Field Strength24.0%
Application21.2%
End User19.0%
Component Type22.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.1
- Europe25.8
- Asia Pacific18.7
- Latin America14.2
- Middle East and Africa11.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bruker Corporation | 76 | 78 | 89 | 91 | 86 | 85 | 84 |
| Agilent Technologies (formerly Varian Medical Systems) | 89 | 86 | 73 | 86 | 88 | 88 | 85 |
| Aspect Imaging | 77 | 79 | 80 | 63 | 62 | 81 | 74 |
| MR Solutions | 66 | 82 | 65 | 80 | 73 | 58 | 71 |
| Magritek | 51 | 68 | 61 | 67 | 56 | 56 | 60 |
| nanoScan (Mediso) | 46 | 67 | 54 | 47 | 46 | 48 | 51 |
| MR Instruments Inc. | 65 | 59 | 41 | 59 | 50 | 49 | 54 |
| Bruker BioSpin | 35 | 60 | 35 | 44 | 49 | 42 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bruker Corporation
- Agilent Technologies (formerly Varian Medical Systems)
- Aspect Imaging
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bruker Corporation | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Agilent Technologies (formerly Varian Medical Systems) | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Aspect Imaging | ◐ | ◐ | ◐ | ◐ | − | ✓ |
| MR Solutions | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Magritek | − | − | − | − | ◐ | − |
| nanoScan (Mediso) | − | ◐ | ◐ | − | − | − |
| MR Instruments Inc. | ◐ | ◐ | − | − | ◐ | − |
| Bruker BioSpin | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Agilent Technologies (formerly Varian Medical Systems)85
2Bruker Corporation84
3Aspect Imaging74
4MR Solutions71
5Magritek60
6MR Instruments Inc.54
7nanoScan (Mediso)51
8Bruker BioSpin44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bruker CorporationAgilent Technologies (formerly Varian Medical Systems)
Challenger2
Strong scale, closing on the leaders.
Aspect ImagingMR Solutions
Contender1
Focused players with pockets of strength.
Magritek
Niche3
Specialists in a single segment or region.
nanoScan (Mediso)MR Instruments Inc.Bruker BioSpin
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Magnet Type in North America, then scale across Preclinical MRI Equipment Market — a $158M beachhead inside a $2.58B market.
Beachhead (SOM)$158Mobtainable near-term
Serviceable (SAM)$950Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Superconducting MRI
Best fit — highest urgency & budget in Magnet Type.
Economic buyer79 fit
Permanent MRI
Strong fit — clear ROI and a fast path to value.
End user65 fit
Resistive MRI
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Magnet Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Field Strength & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve24%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Magnet Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Preclinical MRI Equipment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won8%
$20.3KCAC
$107KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Preclinical MRI Equipment Market is a high-growth opportunity — $10.2B by 2033, compounding at 10.6%.
TAM · 2025$4.56Btoday
TAM · 2033$10.2Bforecast
CAGR10.6%2027–2033
Cumulative$63.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.2BTotal addressable market
SAM$3.84BServiceable available market
SOM$808MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.6% CAGR
Demand compounds through 2033, outpacing GDP across Magnet Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Magnet Type moving from early to mainstream — durable secular demand.
Consolidation upside
8+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.2BLarge & growingTAM by 2033 at 10.6% CAGR
$3.84BServiceable nowreachable with today’s model
$808MBeachhead winobtainable near-term share
8+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.98BBear6.9% CAGR
$10.2BBase10.6% CAGR
$13.1BBull14.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Field Strength optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Preclinical MRI Equipment Market — a $6.88B market by 2033. Plan: grow share from 8.5% to 13.7%.
Market size · 2033$6.88Btotal addressable
Market CAGR10.6%2027–2033
Target share13.7%from 8.5% today
Revenue ambition$943Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 13.7% | On track |
| Revenue | $641M | $943M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 31.4% | 39.9% | On track |
| Customer retention | 87.0% | 96.5% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Magnet Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Field Strength capability
A defensible second engine — invest in Field Strength to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Magnet Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Field Strength
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $96M capacity & capability investment
- Greenlight bolt-on M&A in Field Strength
- Authorise North America expansion plan
- Fund R&D program for Magnet Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Preclinical MRI Equipment Market conversation — a $4.63B market you can size, segment and defend in minutes.
Market size · 2033$4.63Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,025+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Magnet Type
Goal Grow share in Magnet Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 4 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
8+players profiled in this market
Coverage includes
Bruker CorporationAgilent Technologies (formerly Varian Medical Systems)Aspect ImagingMR SolutionsMagriteknanoScan (Mediso)MR Instruments Inc.Bruker BioSpin
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Preclinical MRI Equipment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Preclinical MRI Equipment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Amyotrophic Lateral Sclerosis Drugs Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSilicone Foley Catheter Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAmyotrophic Lateral Sclerosis Device Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportDermal Infilling Materials Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportNon imaging Diagnostic Catheter Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportNon absorbable Surgical Suture Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportAmyloid Oligomer Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportAmyloglucosidase Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportNeurological Diagnostic Equipment Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportAmylase Testing Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportMetallic Ceramics Crown Market
Market size, share, segmentation and regional forecast.
$851M market · 2025 base year
View reportNeurosurgery Surgical Power Tool Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.